Hepion Pharm Stock Price, News & Analysis
Company Description
Hepion Pharm (OTC Link: CTRVP) is a publicly traded biotechnology company in the Healthcare sector.
On a trailing twelve-month basis, Hepion Pharm reported net income of -$8.3M and diluted earnings per share of $-0.88.
This page provides a comprehensive overview of CTRVP stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Latest News
SEC Filings
Hepion Pharm has filed 5 recent SEC filings, including 3 Form 3, 1 Form 8-K, 1 Form 10-K. The most recent filing was submitted on March 18, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CTRVP SEC filings →
Financial Highlights
operating income reached -$4.2M, and net income was -$8.3M. Diluted earnings per share stood at $-0.88. The company generated -$3.3M in operating cash flow. With a current ratio of 10.25, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Days to Cover History
CTRVP Company Profile & Sector Positioning
Hepion Pharm (CTRVP) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.